Gildan Activewear Tumbles Most in Six Years on Jehoshaphat's Revenue Fraud Allegation

The Quick Take

• Gildan Activewear shares fell the most in over six years after Jehoshaphat Research accused the company of inflating revenue.
• The short seller's report triggered an immediate and severe institutional selloff in Gildan's North American-listed shares.
• Gildan supplies wholesale blank apparel markets and operates a vertically integrated manufacturing chain across Central America and Bangladesh.

Gildan Activewear, one of the largest manufacturers of blank T-shirts, hoodies, and sportswear in North America, experienced its worst single-session stock decline in more than six years after activist short seller Jehoshaphat Research published allegations of revenue inflation. Short seller campaigns targeting manufacturing and apparel companies are relatively uncommon compared to tech or biotech sectors, making the Jehoshaphat report a high-impact event that forces investors and auditors to revisit revenue recognition practices. Gildan supplies wholesale channels including screen printers, branded merchandise producers, and major retailers across the United States and Canada.

The severity of the share price decline reflects institutional capital rapidly exiting positions ahead of any formal regulatory or accounting review triggered by the short report. Gildan's competitors in the blank apparel wholesale segment — Hanes Brands and Delta Galil — may see brief sentiment relief as capital rotates away from GIL, though cross-contamination risk from any sector-wide accounting scrutiny could dampen the comparative advantage. Canadian dual-listed securities with US manufacturing exposure face heightened scrutiny from retail and institutional investors following this event, raising the effective risk premium for similar issuers already navigating complex supply chain disclosures.

Gildan's formal response to Jehoshaphat's specific revenue inflation claims will be the key short-term catalyst — denial, partial concession, or restatement guidance each carry materially different implications for share recovery timeline and magnitude. Auditor engagement and Audit Committee communication will be closely watched by institutional holders. The macro variable is whether the SEC or OSC initiates a formal inquiry: regulatory engagement historically extends the selloff timeline by months, while management rebuttals without regulatory action typically allow 6-8 week recovery cycles in contested short seller campaigns against established manufacturers.

Synthesized from 1 source.